Вклад участника
- 19:53, 17 мая 2024 (разн. | история) . . (+3521) . . Н RHAPSODY-Rationale-regarding-and-style-of-a-vital-Cycle-Three-or-more-demo-to-guage-effectiveness-and-also-safety-involving-rilonacept-a-good-interleukin1-along-with-interleukin1-trap-inside-patients-using-persistent-pericarditis-d (RHAPSODY-Rationale-regarding-and-style-of-a-vital-Cycle-Three-or-more-demo-to-guage-effectiveness-and-also-safety-involving-rilonacept-a-good-interleukin1-along-with-interleukin1-trap-inside-patients-using-persistent-pericarditis-d) (текущая)
- 19:50, 17 мая 2024 (разн. | история) . . (+3521) . . Н RHAPSODY-Reason-for-and-design-of-your-vital-Phase-3-test-to-gauge-usefulness-as-well-as-protection-involving-rilonacept-an-interleukin1-and-interleukin1-snare-throughout-patients-using-frequent-pericarditis-n (RHAPSODY-Reason-for-and-design-of-your-vital-Phase-3-test-to-gauge-usefulness-as-well-as-protection-involving-rilonacept-an-interleukin1-and-interleukin1-snare-throughout-patients-using-frequent-pericarditis-n) (текущая)